Alto Neuroscience Stock (NYSE: ANRO) stock price, news, charts, stock research, profile.
Open | $12.920 |
Close | $12.470 |
Volume / Avg. | 89.015K / 174.951K |
Day Range | 12.170 - 13.065 |
52 Wk Range | 12.400 - 24.000 |
Market Cap | $380.677M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 38 |
Short Interest | 11.76% |
Days to Cover | 28.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alto Neuroscience (NYSE: ANRO) through any online brokerage.
Other companies in Alto Neuroscience’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and Xeris Biopharma Holdings (NASDAQ:XERS).
The latest price target for Alto Neuroscience (NYSE: ANRO) was reported by Stifel on Monday, March 25, 2024. The analyst firm set a price target for 32.00 expecting ANRO to rise to within 12 months (a possible 125.99% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Alto Neuroscience (NYSE: ANRO) is $14.16 last updated May 14, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Alto Neuroscience.
Alto Neuroscience’s Q2 earnings are confirmed for Friday, August 2, 2024.
There is no upcoming split for Alto Neuroscience.
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.